Pull to refresh
Logo
Dr. Mehmet Oz

Dr. Mehmet Oz

Administrator of the Centers for Medicare & Medicaid Services (CMS)

Appears in 3 stories

Office: Administrator for the Centers for Medicare and Medicaid Services
Born: June 11, 1960, Cleveland
Party: Republican Party
Education: Harvard University, The Wharton School, Perelman School of Medicine at the University of Pennsylvania

Last updated Nov 1, 2026

Stories

Trump administration cancels ACA coverage for hundreds of thousands over fraud claims

Rule Changes

Announced the cancellations with Vance; imposed broker freeze

On Aug. 31, CMS canceled 315,000 ACA marketplace policies covering 760,000 people, citing suspected fraud. The White House made the move public Sept. 22, saying brokers enrolled many without their knowledge and some enrollees may not exist; since then, CMS has reinstated a small number of people whose coverage was wrongly canceled and cut subsidies for 189,000 enrollees with duplicate or deceased coverage, saving $738 million.

Updated Oct 15

CMS and FDA launch RAPID pathway for breakthrough device coverage

Rule Changes

As of May 2026: Co-announcing RAPID pathway

For nearly a decade, medical device makers have faced the same bottleneck: the FDA clears a breakthrough device, and then Medicare spends another year or more deciding whether to pay for it. On April 23, 2026, the two agencies jointly announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway — it cuts that timeline to as little as two months. They simultaneously paused the existing Transitional Coverage for Emerging Technologies (TCET) program for new applicants, consolidating all breakthrough-device coverage work under RAPID.

Updated May 31

Trump orders a fast-track marijuana reschedule to Schedule III—reviving a stalled Biden-era process

Rule Changes

As of May 2026: Announced Medicare-related CBD access pilot tied to the executive order

Trump's executive order instructing DOJ to fast-track marijuana's move to Schedule III immediately triggered a familiar split. Public health and industry groups cheered the potential research and tax impacts, while House Republicans organized opposition, urging Trump to keep marijuana in Schedule I.

Updated May 15